The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) traded up 8.6% on Thursday . The company traded as high as $0.77 and last traded at $0.73. 366,739 shares changed hands during mid-day trading, a decline ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

During a Case-Based Roundtable® event, Nitin Jain, MD, and participants discussed treating a patient with CLL after ...

Alerts delivered via the electronic health record temporarily reduces unnecessary screening and treatment but does not create ...

A new blood test has been found to detect early stage pancreatic cancer with 85% accuracy when used alongside a carbohydrate antigen 19-9 test, according to a study published Feb. 12 in Science ...

Although CAR T-cell therapies have been found effective against certain difficult-to-treat malignancies, they are not devoid of safety concerns.